Clincosm LogoSign in Get a demo

Health2016: Monitoring Chronic Disease and Risk Factors in the General Population

Sponsor
Glostrup University Hospital, Copenhagen (Other)
Overall Status
Unknown status
CT.gov ID
NCT02720809
Collaborator
(none)
1,500
Enrollment
1
Location
17
Duration (Months)
88.1
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

Health2016 is a general population cross-sectional study aimed at completing af monitoring program for monitoring chronic disease and risk factors in the period 2006 to 2016. Similar studies have been performed in 2006, 2010, and 2013.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    A random sample of 18-69 year-olds living in 10 municipalities in the Capital Region of Denmark is invited to a health examination including measurements of anthropometry, lifestyles, symptoms and diagnoses of diseases, blood pressure, resting heart rate, muscle strength, fitness, lung function, allergy tests, and biochemistry (lipids, liver and kidney function, vitamin D status, salt excretion, iodine status). Trends in these parameters over time will be assessed.

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    1500 participants
    Observational Model:
    Cohort
    Time Perspective:
    Cross-Sectional
    Official Title:
    Helbred2016: Monitorering af Kroniske Sygdomme og Risikofaktorer i Befolkningen
    Study Start Date :
    May 1, 2016
    Anticipated Primary Completion Date :
    Aug 1, 2017
    Anticipated Study Completion Date :
    Oct 1, 2017

    Outcome Measures

    Primary Outcome Measures

    1. Change in micronutrient status from 2006 to 2016 [10 years]

      Serum 25-OH Vitamin D status (nmol/l) in serum from 2006 to 2016

    Secondary Outcome Measures

    1. Change in HbA1C from 2006 to 2016 [10]

      Changes in HbA1C from 2006 to 2016

    2. Change in allergic respiratory disease from 2006 to 2016 [10 years]

      Changes in prevalence of skin prick test reactivity to inhalant allergens

    3. Change in prevalence of hypertension from 2006 to 2016 [10 years]

      Blood pressure above 140/90 or treatment for hypertension

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 69 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes

    Inclusion Criteria: General population sample randomly selected from persons living in 10 municipalities in the Capital Region of Denmark. Age 18-69 years. Danish citizenship, born in Denmark

    Exclusion Criteria:
    • pregnancy

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Research Centre for Prevention and Health Copenhagen Glostrup Denmark DK-2600

    Sponsors and Collaborators

    • Glostrup University Hospital, Copenhagen

    Investigators

    • Principal Investigator: Allan Linneberg, MD, PhD, Center for Health, The Capital Region of Denmark

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Allan Linneberg, Head of Section, Glostrup University Hospital, Copenhagen
    ClinicalTrials.gov Identifier:
    NCT02720809
    Other Study ID Numbers:
    • H-15017277
    First Posted:
    Mar 28, 2016
    Last Update Posted:
    Mar 28, 2016
    Last Verified:
    Mar 1, 2016
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Keywords provided by Allan Linneberg, Head of Section, Glostrup University Hospital, Copenhagen
    micronutrients
    blood pressure
    allergy
    lung function
    Additional relevant MeSH terms:
    Respiration Disorders
    Respiratory Tract Diseases
    Cardiovascular Diseases

    Study Results

    No Results Posted as of Mar 28, 2016